These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 28698670)

  • 1. Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort.
    Jia R; Shepheard S; Jin J; Hu F; Zhao X; Xue L; Xiang L; Qi H; Qu Q; Guo F; Rogers ML; Dang J
    Sci Rep; 2017 Jul; 7(1):5127. PubMed ID: 28698670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR206 and 423-3p Are Differently Modulated in Fast and Slow-Progressing Amyotrophic Lateral Sclerosis Patients.
    Musarò A; Dobrowolny G; Cambieri C; Libonati L; Moret F; Casola I; Laurenzi G; Garibaldi M; Inghilleri M; Ceccanti M
    Neuromolecular Med; 2024 Mar; 26(1):5. PubMed ID: 38491246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainability-Driven Accelerated Shear-Mediated Immunoassay for Amyotrophic Lateral Sclerosis Detection.
    Luo X; Heydari A; Renfrey D; Gardner Z; He S; Tang Y; Weiss G; Rogers ML; Raston C
    ChemSusChem; 2024 Jul; ():e202401008. PubMed ID: 38987226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis.
    Gustafson MP; Staff NP; Bornschlegl S; Butler GW; Maas ML; Kazamel M; Zubair A; Gastineau DA; Windebank AJ; Dietz AB
    PLoS One; 2017; 12(7):e0182002. PubMed ID: 28742871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of de novo mutations in the development of amyotrophic lateral sclerosis.
    van Doormaal PTC; Ticozzi N; Weishaupt JH; Kenna K; Diekstra FP; Verde F; Andersen PM; Dekker AM; Tiloca C; Marroquin N; Overste DJ; Pensato V; Nürnberg P; Pulit SL; Schellevis RD; Calini D; Altmüller J; Francioli LC; Muller B; Castellotti B; Motameny S; Ratti A; Wolf J; Gellera C; Ludolph AC; van den Berg LH; Kubisch C; Landers JE; Veldink JH; Silani V; Volk AE
    Hum Mutat; 2017 Nov; 38(11):1534-1541. PubMed ID: 28714244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis.
    Feldman EL; Goutman SA; Petri S; Mazzini L; Savelieff MG; Shaw PJ; Sobue G
    Lancet; 2022 Oct; 400(10360):1363-1380. PubMed ID: 36116464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.
    Goutman SA; Hardiman O; Al-Chalabi A; Chió A; Savelieff MG; Kiernan MC; Feldman EL
    Lancet Neurol; 2022 May; 21(5):480-493. PubMed ID: 35334233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature.
    Longinetti E; Fang F
    Curr Opin Neurol; 2019 Oct; 32(5):771-776. PubMed ID: 31361627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory Failure in Amyotrophic Lateral Sclerosis.
    Niedermeyer S; Murn M; Choi PJ
    Chest; 2019 Feb; 155(2):401-408. PubMed ID: 29990478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
    Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
    Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Plasticity Modulator p75 Neurotrophin Receptor in Human Urine after Different Acute Brain Injuries-A Prospective Cohort Study.
    Hellström S; Sajanti A; Srinath A; Bennett C; Girard R; Cao Y; Frantzén J; Koskimäki F; Falter J; Lyne SB; Rantamäki T; Takala R; Posti JP; Roine S; Puolitaival J; Jänkälä M; Kolehmainen S; Rahi M; Rinne J; Castrén E; Koskimäki J
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: what is the evidence?
    Jourdi G; Fleury S; Boukhatem I; Lordkipanidzé M
    Neural Regen Res; 2024 Mar; 19(3):536-541. PubMed ID: 37721281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis.
    Stansberry WM; Pierchala BA
    Front Mol Neurosci; 2023; 16():1238453. PubMed ID: 37692101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications.
    Sanchez-Tejerina D; Llaurado A; Sotoca J; Lopez-Diego V; Vidal Taboada JM; Salvado M; Juntas-Morales R
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Correlates Identify ProBDNF and Thrombo-Inflammatory Markers as Key Predictors of Circulating p75
    Fleury S; Schnitzer ME; Ledoux-Hutchinson L; Boukhatem I; Bélanger JC; Welman M; Busseuil D; Tardif JC; D'Antono B; Lordkipanidzé M
    Front Aging Neurosci; 2022; 14():821865. PubMed ID: 35264944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis.
    Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS
    Brain; 2022 Jun; 145(5):1598-1609. PubMed ID: 35202463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75
    Simmons DA; Mills BD; Butler Iii RR; Kuan J; McHugh TLM; Akers C; Zhou J; Syriani W; Grouban M; Zeineh M; Longo FM
    Neurotherapeutics; 2021 Apr; 18(2):1039-1063. PubMed ID: 33786806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Glycolysis in Neurodegenerative Diseases.
    Bell SM; Burgess T; Lee J; Blackburn DJ; Allen SP; Mortiboys H
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant).
    Vucic S; Ryder J; Mekhael L; Rd H; Mathers S; Needham M; Dw S; Mc K;
    Medicine (Baltimore); 2020 Feb; 99(6):e18904. PubMed ID: 32028398
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.